Prolactinoma laboratory tests: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(20 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Prolactinoma}}
{{Prolactinoma}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}};{{AE}} {{Anmol}}, {{Faizan}}


==Overview==
==Overview==
Laboratory findings consistent with the diagnosis of prolactinoma include elevated prolactin levels and reduced thyroid hormone levels.
Laboratory findings consistent with the diagnosis of [[prolactinoma]] include markedly elevated [[prolactin]] levels.


==Laboratory Findings==
==Laboratory Findings==
Laboratory findings consistent with the diagnosis of prolactinoma include elevated prolactin levels and reduced thyroid hormone levels. Prolactin blood levels are tested in women with unexplained milk secretion ([[galactorrhea]]) or irregular [[menses]] or [[infertility]], and in men with impaired sexual function and, in rare cases, milk secretion.
*'''Prolactin levels''' - Serum [[prolactin]] concentration may be markedly higher than normal (usually >200ng/ml).
*'''TSH levels''' - [[Thyrotropin-releasing hormone|Thyrotropin releasing hormone]] ([[Thyrotropin-releasing hormone|TRH]]) stimulates [[prolactin]] secretion. [[Thyroid-stimulating hormone|Thyroid stimulating hormone]] ([[Thyroid-stimulating hormone|TSH]]) is measured. If [[Thyroid-stimulating hormone|TSH]] is elevated, free [[thyroxine]] ([[T4]]) level must be checked to confirm that [[Thyroid-stimulating hormone|TSH]] elevation is due to elevated [[Thyrotropin-releasing hormone|TRH]] and not due to decreased [[Thyroxine|T4]] ([[hypothyroidism]]).
*'''Pregnancy test''' - A [[Pregnancy test|urine pregnancy test]] ([[beta-hCG]]) is performed as [[pregnancy]] causes a [[physiologic]] rise in [[prolactin]] levels.
*'''Serum testosterone levels''' - Low levels of serum [[testosterone]] are found in males presenting with [[symptoms]] of [[hypogonadism]].
*'''IGF-1''' - [[Insulin-like growth factor-1]] levels may be done in patients with features suggestive of [[acromegaly]].
*'''Cortisol levels''' - [[Cortisol]] levels may be done in patients with features suggestive of [[Cushing's syndrome]].
*'''LFT''' - [[Liver function tests]] may be done in patients with appropriate history to exclude [[cirrhosis]] or [[viral hepatitis]] as the cause of elevated [[prolactin]].
*'''RFT''' - [[Renal function tests]] may be done in patients with appropriate history to exclude [[chronic renal failure]] as the cause of elevated [[prolactin]].


:*Prolactin levels in blood: The blood level of prolactin in patients with prolactinoma may be higher than normal(>250 ng/ml).
====Hook effect====
:*Testosterone levels in men: Blood levels of testosterone in men with prolactinoma may decrease.
*The hook effect is a phenomenon which occurs particularly in macroprolactinoma.<ref name="pmid8729527">{{cite journal| author=St-Jean E, Blain F, Comtois R| title=High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. | journal=Clin Endocrinol (Oxf) | year= 1996 | volume= 44 | issue= 3 | pages= 305-9 | pmid=8729527 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8729527  }} </ref>
:*[[Thyroid]] function tests are done([[hypothyroidism]]) if prolactin is elevated.
*In patients with macroprolactinoma, the reading of the initial [[prolactin]] level may be normal or mildly increased.
*These false values are due a large amount of [[Antigen|antigens]], so this is also called the 'high dose hook effect'.
*All patients with [[pituitary]] macroadenomas should undergo an immunoradiometric [[prolactin]] assay with multiple dilutions, if [[prolactinoma]] is suspected.


== References ==
== References ==
Line 18: Line 27:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Neuroendocrinology]]
[[Category:Neuroendocrinology]]
[[Category:Mature chapter]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Up-To-Date]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 23:49, 29 July 2020

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma laboratory tests

CDC on Prolactinoma laboratory tests

Prolactinoma laboratory tests in the news

Blogs on Prolactinoma laboratory tests

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]

Overview

Laboratory findings consistent with the diagnosis of prolactinoma include markedly elevated prolactin levels.

Laboratory Findings

Hook effect

  • The hook effect is a phenomenon which occurs particularly in macroprolactinoma.[1]
  • In patients with macroprolactinoma, the reading of the initial prolactin level may be normal or mildly increased.
  • These false values are due a large amount of antigens, so this is also called the 'high dose hook effect'.
  • All patients with pituitary macroadenomas should undergo an immunoradiometric prolactin assay with multiple dilutions, if prolactinoma is suspected.

References

  1. St-Jean E, Blain F, Comtois R (1996). "High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas". Clin Endocrinol (Oxf). 44 (3): 305–9. PMID 8729527.


Template:WikiDoc Sources